Literature DB >> 3293555

Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance, and computed tomographic correlations.

D G Lichter1, A J Corbett, G M Fitzgibbon, O R Davidson, J K Hope, G V Goddard, K J Sharples, M Pollock.   

Abstract

The neuropathologic and pathophysiological relationship of specific to more generalized cognitive dysfunction in Parkinson's disease (PD) remains incompletely understood. This issue was examined in a study of 39 patients with PD, utilizing standardized clinical measures, computerized neuropsychological tests, and quantitative computed tomography. Disorders of visuospatial discrimination and perceptual-motor function closely paralleled motor scores, suggesting a common neuropathologic basis. Caudate nuclear and mesocortical dopamine depletion play a role in this context. More generalized cognitive dysfunction occurred in older patients with a somewhat longer disease duration, more advanced parkinsonism, and computed tomographic evidence of subcortical and frontal cortical atrophy but without significant cerebral atrophy when compared with age-matched controls. Further prospective clinicopathologic studies will be required to clarify the relative contribution of the primary dopaminergic dysfunction, age-related changes, Alzheimer-type pathologic condition, and other coexisting neurotransmitter deficits to the dementia seen in PD.

Entities:  

Mesh:

Year:  1988        PMID: 3293555     DOI: 10.1001/archneur.1988.00520320040013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

Review 1.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

2.  Cognitive function in patients with Parkinson's disease undergoing stereotaxic thalamotomy.

Authors:  M Lund-Johansen; K Hugdahl; K Wester
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

3.  Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels.

Authors:  Serge Sevy; Youssef Hassoun; Antoine Bechara; Eldad Yechiam; Barbara Napolitano; Katherine Burdick; Howard Delman; Anil Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

Review 4.  Amnestic disorders. Pathophysiology and patterns of memory dysfunction.

Authors:  K R Erickson
Journal:  West J Med       Date:  1990-02

5.  Substantia innominata: MR findings in Parkinson's disease.

Authors:  Hirobumi Oikawa; Makoto Sasaki; Shigeru Ehara; Takashi Abe
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

6.  Usefulness of movement time in the assessment of Parkinson's disease.

Authors:  M Zappia; R Montesanti; R Colao; A Quattrone
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

Review 7.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

8.  Cognitive Impairment in Parkinson's Disease: Is It a Unified Phenomenon?

Authors:  Anja Lowit; Peter Howell; Bettina Brendel
Journal:  Brain Impair       Date:  2005       Impact factor: 1.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.